Sera Prognostics (SERA) Non Operating Income (2020 - 2026)
Sera Prognostics' (SERA) quarterly Non Operating Income came in at $963000.0 in Q1 2026, down 9.75% YoY from $1.1 million in Q1 2025, and down 10.34% on a QoQ basis from $1.1 million in Q4 2025.
Sera Prognostics (SERA) Non Operating Income (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of Non Operating Income data on file, last reported at $963000.0 in Q1 2026.
- Quarterly Non Operating Income fell 9.75% year-over-year to $963000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (up 17.21% YoY) and the FY2025 annual result came in at $4.6 million, up 21.78% from the prior year.
- Non Operating Income declined to $963000.0 in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.3 million in Q2 2025 to a low of $96000.0 in Q1 2022.
- A 5-year average of $851411.8 and a median of $948000.0 in 2024 frame the typical range for Non Operating Income.
- The widest YoY moves for Non Operating Income: up 2159.09% in 2022, down 77.24% in 2022.
- Tracing SERA's Non Operating Income over 5 years: stood at $690000.0 in 2022, then surged by 35.36% to $934000.0 in 2023, then fell by 8.99% to $850000.0 in 2024, then gained by 26.35% to $1.1 million in 2025, then dropped by 10.34% to $963000.0 in 2026.
- The last three Non Operating Income figures came in at $963000.0 (Q1 2026), $1.1 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 46.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Sera Prognostics | 103.48 Mn | 103.48 Mn | -20,000.00 | 867,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 867,000.00 |
| Mar 31, 2026 | 963,000.00 |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 850,000.00 |
| Sep 30, 2024 | 948,000.00 |
| Jun 30, 2024 | 958,000.00 |
| Mar 31, 2024 | 1.01 Mn |
| Dec 31, 2023 | 934,000.00 |
| Sep 30, 2023 | 988,000.00 |
| Jun 30, 2023 | 932,000.00 |
| Mar 31, 2023 | 780,000.00 |
| Dec 31, 2022 | 690,000.00 |
| Sep 30, 2022 | 497,000.00 |
| Jun 30, 2022 | 244,000.00 |
| Mar 31, 2022 | 96,000.00 |
| Dec 31, 2021 | 65,000.00 |
| Sep 30, 2021 | 22,000.00 |